Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться
Свежие комментарии